Handheld Narrowband UVB Device Therapy Effective and Safe for Vitiligo Treatment, suggests a study published in the Indian ...

In contrast, the placebo group saw a 9.2% change. The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to a study. The study ...

Shares of Anterix (ATEX) are up $1.37, or 5%, to $29.20 in Friday morning trading after the Federal Communications Commission proposed to ...

Discover a recent study that evaluated the efficacy and safety of combining baricitinib, with narrowband UV-B phototherapy in adults with severe, active, nonsegmental vitiligo.